WVE NASDAQ
Wave Life Sciences Ltd.
1W: -7.0%
1M: -13.0%
3M: -52.4%
YTD: -59.8%
1Y: -1.8%
3Y: +73.0%
5Y: +3.4%
$6.38
-0.04 (-0.62%)
Weekly Expected Move ±7.3%
$6
$6
$7
$7
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$43M
-60.5% ▼
5Y CAGR: +16.3%
Gross Profit
$34M
-68.7% ▼
Operating Income
-$215M
-95.1% ▼
Net Income
-$204M
-110.7% ▼
EPS (Diluted)
$-1.21
-72.9% ▼
EBITDA
-$196M
-92.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $41M | $4M | $113M | $108M | $43M |
| YoY Growth | +104.0% | -91.1% | +3005.1% | -4.4% | -60.5% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $9M |
| Gross Profit | $41M | $4M | $113M | $108M | $34M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 79.3% |
| R&D Expenses | $122M | $116M | $130M | $160M | $183M |
| SG&A Expenses | $46M | $51M | $51M | $59M | $75M |
| Operating Expenses | $168M | $166M | $181M | $219M | $249M |
| Operating Income | -$127M | -$163M | -$68M | -$110M | -$215M |
| Operating Margin | -310.1% | -4459.3% | -60.0% | -101.9% | -504.1% |
| Interest Expense | — | $0 | $0 | $0 | $0 |
| Income Before Tax | -$122M | -$161M | -$58M | -$97M | -$204M |
| Tax Expense | -$204K | $681K | -$677K | $0 | $0 |
| Net Income | -$122M | -$162M | -$58M | -$97M | -$204M |
| Net Margin | -298.4% | -4434.7% | -50.8% | -89.6% | -478.3% |
| EPS (Diluted) | $-2.36 | $-2.05 | $-0.54 | $-0.70 | $-1.21 |
| EBITDA | -$117M | -$153M | -$59M | -$102M | -$196M |
| Shares Outstanding | 52M | 79M | 106M | 138M | 169M |